-
GABA in the Basal Ganglia Tracks Motor Severity and Response to BoNT Treatment in Cervical Dystonia
-
GAD-Positive Versus GAD-Negative Stiff Person Syndrome: A Retrospective Study
-
Gait Analysis in the 6-Hydroxydopamine Hemiparkinson Rat Model with Deep Brain Stimulation in the Subthalamic nucleus
-
Gait and turning during daily life across the spectrum of normal, prodromal, early and moderate Parkinson’s disease
-
Gait Digital Outcomes Exploration from Continuous Real-World Recordings in Parkinson’s Disease
-
Gaps in Diagnosing and Treating Tic Disorders in Latin America: A Survey of Healthcare Workers
-
Gastrointestinal Dysbiosis and Clinical Outcomes in Parkinson’s Disease
-
Gathering Prodromal Participant Perspective on Receiving Personal Research Information
-
GBA Mutation Profile in Parkinson’s Disease: Insights from a Movement Disorders Center in Brazil
-
GBA1 deficiency differentially affects endolysosomal trafficking in neurons and astrocytes
-
Gender Differences Following Bilateral STN DBS Surgery in Parkinson’s Disease
-
Gender Differences in Physical Activity in Parkinson’s Disease
-
Gender Disparities in Daytime Sleepiness Among Hispanic Individuals with Parkinson’s Disease: A Cross-Sectional Study
-
Gender Disparities in Depressive Symptoms among Hispanic Parkinson’s Disease Patients: A Cross-Sectional Study
-
Gender Disparities in Quality of Life Domains Among Hispanic Individuals with Parkinson’s Disease: A Comparative Analysis
-
Gender specificity in AI-Based Screening Diagnostics of Parkinson’s Disease (Brainphone Project)
-
Gender-Based Differences in Sleep Quality Among Hispanic Parkinson’s Disease Patients
-
Gender-related Cognitive Disparities in Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study
-
Genetic Analysis of Mendelian mutations in A Large Chinese Early-onset and Familial Parkinson’s Disease
-
Genetic Analysis of UK Kindreds with Familial Tremor in The Global Parkinson’s Genetics Progam (GP2)
-
Genetic Architecture Of Movement Disorder And Its Association With Consanguinity In Pashtoon Population
-
Genetic determinants of the progression of Lewy body pathology
-
Genetic Heterogeneity in Chorea-Acanthocytosis Revealed by Varying VPS13A Mutations Within a Consanguineous Family
-
Genetic Migration Dynamics: Unraveling the Influence of Internal Migration on Huntington’s Disease Prevalence in the Amazonas State.
-
Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population
-
Genetic signatures stratify PwP into three subgroups with differing responses in two disease-modifying Phase 3 trials and indicate multiple disease biology pathways to Parkinson’s Disease
-
Genetic Study of polymorphism of cytokines in Parkinson’s disease.
-
Genetic Variant in the VPS16 Gene in a 44-year-old Patient with Generalized Dystonia
-
Genetic Variants and Levodopa Response in Parkinson’s Disease: Insights from MAO-B and DAT1 Polymorphisms
-
Genome-wide Assessment of Homozygosity in Parkinson’s Disease Across Diverse Ancestral Population
-
Genome-Wide Association Study revealing novel risk loci associated with Age at Onset of Parkinson’s Disease
-
Genome-wide Survival Analysis Identified Association Between HS1BP3 and APOE loci and Dementia in Parkinson’s disease
-
Get Ready a mobile phone app a solution for patient engagement/remote management
-
Giant Aneurysm Causing Parkinsonism and REM Sleep Disorder
-
Global presence and penetrance of CSF1R-Related disorder
-
Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.
-
GNAO1-related Neurodevelopmental Disorder with Involuntary Movements Inducing a Dyskinetic Status
-
Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study
-
GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.
-
GRoningen Early-PD Ambroxol Treatment (GREAT) Trial: A randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA-mutation
-
Gut Microbial Metabolites and Future Risk of Parkinson’s Disease: A Metabolome-wide Association Study
-
Gut Microbiota May Alter Glucose Metabolism in Patients with Parkinson’s Disease
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.